Aspectos clínicos y epidemiológicos en pacientes con síndrome de inmunodeficiencia adquirida de la provincia de Santiago de Cuba / Clinical and epidemiological features in patients with acquired immunodeficiency syndrome from Santiago de Cuba province

Se realizó un estudio descriptivo, transversal y retrospectivo de 60 pacientes adultos con diagnóstico de síndrome de inmunodeficiencia adquirida, ingresados en el Servicio de Medicina Interna (Sala de Inmunología Clínica) del Hospital General Docente Dr Juan Bruno Zayas Alfonso de Santiago de Cuba, en el período 2014-2016, a fin de caracterizarles según algunas variables clínicas y epidemiológicas seleccionadas para ello. Entre los principales resultados figuraron el predominio del sexo masculino (63,3 por ciento), del grupo etario de 35-44 años (36,7 por ciento) y del tiempo de evolución de la enfermedad de 1 a 4 años (41,7 por ciento). Igualmente pudo concluirse que las enfermedades oportunistas, como la candidiasis orofaríngea y la neurotoxoplasmosis (con 25 y 4 pacientes, respectivamente), presentaron importancia clínica marcada en la evolución de los afectados

A descriptive, cross-sectional and retrospective study of 60 adult patients with diagnosis of acquired immunodeficiency syndrome, admitted in the Internal Medicine Service (clinical Immunology room) of Dr Juan Bruno Zayas Alfonso Teaching General Hospital in Santiago de Cuba was carried out in the period 2014-2016, in order to characterize them according to some clinical and epidemiological variables selected for it. Among the main results there were the prevalence of the male sex (63,3 percent), age group 35-44 years (36,7 percent) and a clinical course of the disease from 1 to 4 years (41,7 percent). Likewise, it could be concluded that the opportunistic diseases, as the oropharyngeal candidiasis and neurotoxoplasmosis (with 25 and 4 patients, respectively) presented a significant clinical importance in the clinical course of the patients affected

Manifestaciones dermatológicas asociadas a la infección por VIH/SIDA / Dermatologic manifestations associated with HIV/AIDS

The ongoing human immunodeficiency virus (HIV) infection epidemic coupled with more efficacious and available treatments has led to a larger number of patients living with HIV or AIDS. As a result, skin manifestations related to HIV/AIDS or its therapy have become increasingly more common and are reported to occur in as many as 95% of patients. Herein, we review the most common HIV/AIDS related cutaneous pathologies and classify them into inflammatory, HAART-associated, neoplastic, and infectious manifestations. Cutaneous manifestations should be promptly recognized and treated by physicians and health care personnel in order to provide optimal care.

La epidemia del virus de la inmunodeficiencia humana (VIH) sumado al mayor acceso a terapias antiretrovirales (TARV) han llevado a un aumento del número y la sobrevida de pacientes que viven con esta infección crónica. Se estima que hasta 95% de los pacientes con infección por VIH/SIDA presentarán alguna manifestación cutánea, por lo cual, debemos conocerlas. En la presente revisión se estudiarán las manifestaciones cutáneas de la infección por el VIH/SIDA clasificadas como: manifestaciones inflamatorias, manifestaciones asociadas a la TARV, manifestaciones neoplásicas y manifestaciones infecciosas asociadas a infección por VIH/SIDA (bacterianas, virales, fúngicas y parasitarias). Estas manifestaciones deben ser reconocidas por los médicos y el personal de salud a cargo del tratamiento y control de los pacientes con esta patología crónica.

Intestinal Parasitosis in Relation to Anti-Retroviral Therapy, CD4+ T-cell Count and Diarrhea in HIV Patients

Intestinal parasitic infections are one of the major causes of diarrhea in human immunodeficiency virus (HIV) seropositive individuals. Antiretroviral therapy has markedly reduced the incidence of many opportunistic infections, but parasite-related diarrhea still remains frequent and often underestimated especially in developing countries. The present hospital-based study was conducted to determine the spectrum of intestinal parasitosis in adult HIV/AIDS (acquired immunodeficiency syndrome) patients with or without diarrhea with the levels of CD4+ T-cell counts. A total of 400 individuals were enrolled and were screened for intestinal parasitosis. Of these study population, 200 were HIV seropositives, and the remaining 200 were HIV uninfected individuals with or without diarrhea. Intestinal parasites were identified by using microscopy as well as PCR assay. A total of 130 (32.5%) out of 400 patients were positive for any kinds of intestinal parasites. The cumulative number of parasite positive patients was 152 due to multiple infections. A significant association of Cryptosporidium (P<0.001) was detected among individuals with CD4+ T-cell counts less than 200 cells/microl.

Risk factors of HIV-related oral lesions in adults / Fatores de risco de lesões bucais associadas ao HIV em adultos / Factores de riesgo de lesiones bucales asociadas al VIH en adultos

OBJECTIVE: To assess the risk factors in the occurrence of oral lesions in HIV-positive adults. METHODS: A retrospective analytical-descriptive survey was conducted using the medical/dental records of 534 patients with oral lesions associated with HIV. The data were collected from five referral centers for managing HIV and associated comorbidities in the city of Porto Alegre, Southern Brazil, between 1996 and 2011. Using a standardized form, socio-demographic and clinical data were recorded. Exclusively and definitively diagnosed oral pathologies were included and classified according to ECC criteria on Oral Problems Related to HIV Infection. For data analysis cross-tabulations, Chi-squared tests and logistic regression models were used where appropriate. RESULTS: CD4+ counts lower than 350 cells/mm³ (p < 0.001), alcohol consumption (p = 0.011) and female gender (p = 0.031) were predisposing factors for oral candidiasis. The occurrence of hairy leukoplakia was independently associated with CD4+ counts below 500 cells/mm³, (p = 0.029) a viral load above 5,000 copies/mm³ (p = 0.003) and smoking (p = 0.005). CONCLUSIONS: Moderate and severe degrees of immunodeficiency and detectable viral loads were risk factors for the onset of oral lesions. Smoking and alcohol consumption also increased susceptibility to the development of opportunistic infections in HIV-positive adults from Porto Alegre, irrespective of the use of antiretroviral therapy.

OBJETIVO: Analisar fatores de risco para a ocorrência de lesões bucais em adultos soropositivos para o HIV. MÉTODOS: Estudo transversal, descritivo analítico de prontuários médicos/odontológicos de 534 pacientes com lesões bucais associadas ao HIV em Porto Alegre, RS, no período de 1996 a 2011. Os dados foram coletados em cinco centros de referência em saúde para o atendimento de portadores do HIV e comorbidades associadas. Os dados sociodemográficos e clínico-laboratoriais foram coletados em formulários padronizados. Foram incluídos dados exclusivamente de lesões com diagnóstico definitivo e classificadas de acordo com os critérios da ECC on Oral Problems Related to HIV Infection. A análise dos dados foi realizada mediante a aplicação de tabulações cruzadas, teste do Qui-quadrado e modelos de regressão logística. RESULTADOS: Níveis de CD4+ < 350 células/mm³ (p < 0,001), consumo de álcool (p = 0,011) e sexo feminino (p = 0,031) foram predisponentes para candidíase bucal. A ocorrência de leucoplasia pilosa foi associada com contagens de CD4+ < 500 células/mm³ (p = 0,029), cargas virais > 5.000 cópias/mm³ (p = 0,003) e tabagismo (p = 0,005). CONCLUSÕES: Graus de imunodeficiência moderados e severos e cargas virais detectáveis foram fatores de risco para o desenvolvimento de lesões bucais. O consumo de tabaco e álcool aumentou a suscetibilidade de desenvolver infecções oportunistas em adultos HIV positivos, independentemente do uso de terapia antirretroviral.

OBJETIVO: Analizar factores de riesgo para la ocurrencia de lesiones bucales en adultos seropositivos para VIH. MÉTODOS: Estudio transversal, descriptivo analítico de prontuarios médicos/odontológicos de 534 pacientes con lesiones bucales asociadas al VIH en Porto Alegre, RS, Brasil, en el período de 1996 a 2011. Los datos se colectaron en cinco centros de referencia en salud para la atención de portadores del VIH y comorbilidades asociadas. Los datos sociodemográficos y clínico-laboratoriales se colectaron en formularios estandarizados. Se incluyeron datos exclusivamente de lesiones con diagnóstico y clasificadas de acuerdo con los criterios de la ECC on Oral Problems Related to HIV Infection. El análisis de los datos fue realizado mediante la aplicación de tabulaciones cruzadas, prueba de Chi-cuadrado y modelos de regresión logística. RESULTADOS: Niveles de CD4+ < 350 células/mm³ (p<0,001), consumo de alcohol (p=0,011) y sexo femenino (p = 0,031) predispusieron para candidiasis bucal. La ocurrencia de leucoplasia pilosa estuvo asociada con contaje de CD4+ < 500 células/mm³ (p = 0,029), cargas virales > 5.000 copias/mm³ (p = 0,003) y tabaquismo (p = 0,005). CONCLUSIONES: Grados de inmunodeficiencia moderados y severos y cargas virales detectables fueron factores de riesgo para el desarrollo de lesiones bucales. El consumo de tabaco y alcohol aumentó la susceptibilidad de desarrollar infecciones oportunistas en adultos VIH positivos, independientemente del uso de terapia anti=retroviral.

Una década de terapia anti-retroviral: Perfil de pacientes con 10 años de triterapia de alta efectividad / A decade of antiretroviral therapy: a profile of patients with 10 years of highly effective triple therapy

Introduction: Highly effective antiretroviral triple therapy (TAR3) has led to a significant increase in survival of patients (pts) infected with human immunodeficiency virus. In 1999 it was started in the Chilean public health system, including Arriarán Foundation (FA) access to TAR, reaching full coverage since 2003. By October 31, 2009 124 pts had reached 10 years of uninterrupted TAR3 in FA. Objective: To describe and analyze the profile of pts, their therapeutic regimen (s) and clinical outcomes during 10 years of TAR3. Methods: Retrospective descriptive study. We reviewed the records of pts who had reached 10 years of uninterrupted TAR3 in FA. Demographic data, baseline and virological staging at start of TAR3, comorbidities and complications were recorded. Drug regimens used were analyzed, as well as toxicity, virological and immunological outcomes, frequency and reasons for change in therapy. Complications were classified as opportunistic and not opportunistic during this evolution and the latest known clinical and laboratory data were registered. A database program based on Excel was used. Results: 121/124 pts were available for analysis, 76.8% male, male-female ratio was 3.3:1. Baseline median age: 36 years (20-69); CD4 cells 176/ mm³ (8-1,224) with 65.3% < 200; median viral load (STL): 60,078 copies/ml (1,100- 7,900,000); 36.3% were in clinical AIDS stage. Patients received an average of 3.5 therapies regimens during the decade (range, 1 [14 pts, 11.5%] to 7 [3 pts, 2.4%]), with average duration of 42 months each and a median of 36 months. As initial TAR3 regimen 2 backbone nucleoside analogues (ITRN) was the most frequent, with a protease inhibitor (PI) in 51.2% and non-nucleoside RTIs (NNRTIs) in 38.8%. Adverse reactions were the main reason for change of therapy (24.7%), followed by virological failure (24.2%) and treatment simplification (16.6%). At the latest assessment, all with > 10 years of TAR3 median CD4 was 602 cells/mm³, 11 pts (9%) had CD4 < 200/mm³; 85.2% had undetectable VL (< 80 copies/mL); the remaining 14.8% had a median of 1,800 copies/mL. Only 2 pts (1.7%) were in AIDS clinical stage. Current regimens were 2 NRTI plus 1 NNRTI in 61 pts (50.4%), 2 or more NRTI plus 1 PI in 46 (38%). Seventy two pts (60.3%) had chronic comorbidities at latest follow up. Dyslipidemia, hypertension, diabetes mellitus and renal failure were the most frequent conditions; 17 pts (14%) had clinical lipodystrophy secondary to TAR. Conclusion: Achieving a decade of TAR is already a reality and in the short term will be routine. This is rarely achieved with the initial therapeutic regimen. The major obstacles to prolonged maintenance of a single therapeutic regimen have been adverse effects and virological failure, although current drugs with better efficacy and safety profile may allow longer use for each regimen. Despite the difficulty of treating these pts, they can achieve long-term survival with good virologic control, immune recovery and absence of opportunistic complications associated with HIV infection. Nonetheless, the high frequency of non opportunistic chronic comorbidities and antiretroviral therapy side effects after prolonged or life-long use is becoming a major issue.

La introducción de la triterapia anti-retroviral de alta efectividad (TAR3) ha llevado a un significativo aumento en la sobrevida de los pacientes infectados por virus de inmunodeficiencia humana. En 1999 se inició en el sistema público de salud chileno, incluida la Fundación Arriarán (FA) el acceso progresivo a TAR3, que alcanzó cobertura completa desde 2003. En FA al 31 de octubre de 2009 se compatibilizaban 124 pacientes (pts) que habían alcanzado 10 años de TAR3 ininterrumpida. Objetivo: Describir y analizar el perfil de los pts, sus terapias y la evolución clínica durante el período de 10 años de TAR3. Material y Método: estudio descriptivo y retrospectivo. Se revisaron las fichas de los pts que alcanzaron 10 años de TAR3 en FA. Se registraron datos demográficos, clínicos y clasificación por etapas, co-morbilidades y complicaciones al inicio de tratamiento. Se analizaron los esquemas terapéuticos recibidos, toxicidades y desenlaces virológicos e inmunológicos, así como la frecuencia y razones de cambio de terapias, las complicaciones oportunistas y no oportunistas durante esta evolución y el último estado clínico y de laboratorio conocido. Se empleó una base de datos en base al programa Excel. Resultados: se lograron analizar 121/124 pts, 76,8% hombres, relación hombre:mujer 3,3:1. Mediana basal: edad, 36 años (20-69); recuento de linfocitos CD4 de 176 céls/mm³ (8-1.224), con 65,3% < de 200 céls/mm³; carga viral (CV): 60.078 copias/ml (1.100 -7.900.000); 44/121 (36,3%) en etapa SIDA clínica inicial. Los pacientes recibieron un promedio de 3,5 esquemas de terapias durante el decenio (rango, 1 [14 pts, 11,5 %] a 7 [3 pts, 2,4 %]), con duración promedio de 42 meses en cada uno y una mediana de 36. TAR3 inicial con dos análogos nucleosídicos (ITRN) fue lo más frecuente, con un inhibidor de la proteasa (IP) en 51,2% o con ITR no nucleosídico (ITRnN) en 38,8%. Las reacciones adversas fueron el principal motivo de cambio de esquemas (24,7%), seguido de fracaso virológico (24,2%) y simplificación terapéutica (16,6%). En su última evaluación y con > 10 años de TAR3 la mediana de linfocitos CD4 era de 602 céls/mm³; había 11 pts (9 %) con CD4 < 200/ mm³; 85,2% estaba con CV indetectable (< 80 copias/ mL), 14 (14,8%) con detectabilidad viral, y éstos con una mediana de 1.800 copias/mL. Sólo 2 pts (1,7%) estaban en etapa clínica de SIDA. El esquema de TAR3 actual más frecuente era de dos ITRN más un ITRnN, en 61 pts (50,4%) y luego dos ITRN más un IP en 46 (38%). En 72 pts (60,3%) se pesquisaron co-morbilidades crónicas: dislipidemias, hipertensión arterial, diabetes mellitus y/o insuficiencia renal; 17 pts (14%) presentaban lipodistrofia clínica secundaria a TAR3 Conclusión: Alcanzar una década de TAR3 ya está siendo una realidad y a corto plazo será rutinario. Esto rara vez se logra con la primera terapia, aunque esquemas contemporáneos más efectivos y seguros pueden hacerlo posible a futuro. Los principales obstáculos para lograr mantención prolongada de un solo esquema terapéutico son los efectos adversos y el fracaso virológico. A pesar de las dificultades terapéuticas estos pts pueden alcanzar sobrevida a largo plazo con buen control virológico, recuperación inmune y control de las complicaciones oportunistas asociadas a la infección por VIH. Destaca la alta frecuente de co-morbilidades crónicas no oportunistas y secuelas de la terapia anti-retroviral.

Ocular Manifestations of Acquired Immunodeficiency Syndrome in Korea

The clinical features of HIV/AIDS-related ocular manifestations in Korean patients were investigated in this study. Data on 200 consecutive Korean patients diagnosed with AIDS who visited the Seoul National University Hospital from January 2003 to June 2008 were reviewed. Fifty-seven patients (28.5%) had ocular manifestations, and they showed significantly lower CD4+ T cell count than patients without ocular manifestations. Among them, 23 (40.3%) patients showed retinal microvasculopathy, and 22 (38.5%) patients showed cytomegalovirus (CMV) retinitis. Other manifestations included retinal vein occlusion (n = 4), herpes zoster ophthalmicus (n = 4), syphilitic uveitis (n = 2), acute retinal necrosis (n = 1), and progressive outer retinal necrosis (n = 1). The mean CD4+ lymphocyte counts of the patients with retinal microvasculopathy and cytomegalovirus retinitis were 108.5 cells/microL and 69.4 cells/microL, respectively. In conclusion, ocular manifestations including CMV retinitis are common complications in Korean patients with AIDS even in the era of highly active anti-retroviral therapy. Compared to previous reports in western countries, prevalence of CMV retinitis is relatively low and CD4+ lymphocytes count at the time of diagnosis is relatively high.

Comparison of oral manifestations with CD4 count in HIV-infected patients.

Aim and Objective: This study was carried out with the primary aim of correlating oral changes and general changes of HIV-infected patients with their CD4 count. Materials and Methods: 124 patients were selected, and after taking their informed consent, they were subjected to detailed history taking and thorough clinical examination. Specific oral lesions and general physical changes were recorded. Every patient was subjected to laboratory investigation for CD4 count. All these findings were tabulated. The clinical observation and laboratory findings were subjected to critical analysis and correlated. Statistical test, i.e. Student's " t" test, was applied and objective conclusions were drawn. Result: Out of 124 patients, 40 had oral candidiasis, 6 had oral hairy leukoplakia, 12 had periodontal disease, 20 had xerostomia, 30 had melanin pigmentation, while 4 had HSV2, and atypical ulceration. Out of 40 patients with oral candidiasis, 28 patients had CD4 count <200 (group A), 10 patients were in group, B (CD4 count 200-500 cell/mm 3 ) and 2 patients in group C(CD4 >500 cell/mm 3 ). Oral hairy leukoplakia occurred in equal proportions in group A and B. These periodontal diseases were more commonly in group B; xerostomia and melanin pigmentation was equally seen in group A and B. Conclusion: Oral candidiasis, oral hairy leukoplakia, linear gingival erythema, necrotizing ulcerative gingivitis, and necrotizing ulcerative periodontitis are specific oral indicators which will definitely suggest to the dental surgeon that the disease is running a rapid downhill course and due to this the oral physician is in a position to raise a suspicion and alert the general physician regarding the declining immune status of patient.

Asociación de manifestaciones bucales con marcadores de seguimiento en personas con VIH, atendidos en el Centro de Atención Integral al Seropositivo Dr Ismael Triana Torres / The association of oral manifestations with follow-up markers in HIV persons, attending the Seropositive Integral Attention Centre Dr. Ismael Triana Torres

Ya hace 25 años que apareció el SIDA, y en las más de dos décadas transcurridas la medicina ha logrado grandes avances en el diagnóstico y en la caracterización clínica de la enfermedad, pero aún no se ha conseguido una cura. Este síndrome está definido por una serie de enfermedades asociadas a la inmunodepresión que produce su agente causal. Las manifestaciones bucales, típicas en personas con VIH/sida (PVs), han sido relacionadas con los marcadores de seguimiento tanto inmunológico como virológico. Nuestro objetivo fue asociar las manifestaciones bucales con marcadores de seguimiento en personas con VIH atendidos en el CAIS Dr. Ismael Triana Torres desde enero de 2003 hasta diciembre de 2007. Se realizó un estudio explicativo, o experimental-retrospectivo. El universo estuvo integrado por 275 pacientes diagnosticados con VIH, y la muestra quedó conformada con 135 individuos, seleccionada estratificadamente. La unidad básica de estudio fue la consulta estomatológica de los pacientes de la muestra. Se emplearon métodos estadísticos descriptivos e inferenciales. La mayor proporción de personas con VIH/sida (PVs) atendidas presentaron estados de inmunodeficiencia moderada (47,66 porciento) y cantidades mínimas de PVs severamente inmuno-deprimidas (5,30 porciento). En la medida en que disminuyó el conteo de linfocitos T CD4+ en PVs se incrementó la probabilidad de aparición de manifestaciones bucales (74,54 porciento) y del total de pacientes con una (CV) de 50 000 copias/mm³ o más el 87,10 porciento presentó manifestaciones bucales. Se demostró asociación significativa entre el conteo de linfocitos T CD4+ y la carga viral con la presencia de manifestaciones bucales en infestados con VIH

Introduction: There have passed already 25 years since AIDS appeared, and in those more than two decades lapsed the medicine has achieved big advances in the diagnose and clinical characterization of the disease, but a cure has not still been gotten. This syndrome is defined by a series of diseases associated to the immunodepression produced by its causal agent. The oral manifestations, typical in people with HIV/AIDS, have been related with follow-up markers both immunologic and virological. Objective: Associating the oral manifestations with the follow up markers in HIV persons attended in the SIAC Dr. Ismael Triana Torres since January 2003 to December 2007. Methods: We carried out an explicative or retrospective-experimental study. The universe was formed by 275 patients diagnosed with HIV, and the sample finally conformed to 135 individuals, selected in an stratified way. The study basic unit was the dentist consultation of the patients integrating the sample. We used statistic, descriptive and inferential methods...

Neumonía bacteriana en pacientes VIH/sida / Bacterial pneumonia in HIV/AIDS patients

Introducción: En los pacientes VIH/sida son múltiples los factores de riesgo que se involucran en la aparición de la neumonía bacteriana de diversa etiología, sin que en ocasiones se conozca el germen causal del cuadro respiratorio. Métodos: Se estudiaron 85 pacientes VIH/sida con diagnóstico de neumonía bacteriana según criterios clínicos, radiológicos y de laboratorio en el Instituto de Medicina Tropical Pedro Kourí, entre noviembre de 2007 y abril de 2008. Resultados: Se identificaron con mayor frecuencia S. pneumoniae (40,5 por ciento), las enterobacterias (28,3 por ciento) y los bacilos no fermentadores (13,5 por ciento). Prevalecieron los individuos menores de 50 años de edad (91,7 por ciento), fumadores (65,9 por ciento), con un conteo de linfocitos TCD4 menor de 200 cél/mm³ (64,7 por ciento)y que emplearon terapia antirretroviral de alta eficacia (54,7 por ciento). Constituyeron factores de riesgo para presentar una neumonía bacteriana por enterobacterias, la edad ³ 50 años (OR 2,50; IC= 95 por ciento 1,40-15,1) y la desnutrición (OR 2,53; IC= 95 por ciento 1,83-7,91). Conclusiones: Se demostró que los agentes etiológicos identificados en esputos de pacientes VIH/sida cubanos con NB, son similares a los descritos por otros autores a nivel internacional, siendo más probable que los enfermos mayores de 50 años y desnutridos presenten una NB causada por enterobacterias que por el resto de los microorganismos

Introduction: In HIV/AIDS patients are many the risk factors involved in appearance of the bacterial pneumonia (BP) of different origin without to know the causal germ of respiratory picture. Methods: Authors studied 85 HIV/AIDS patients diagnosed with BP according the clinical, radiological and laboratory criteria in the "Pedro KourÝ" Tropical Medicine Institute between November, 2007 and April, 2008. Results: S. pneumoniae (40,5 percent), enterobacteria (28,3 percent) and no-fermented bacilli (13,5 percent) were the more frequent identified. There was prevalence of subjects aged under 50 (91,7 percent), smokers (65,9 percent), with a TDC4 lymphocytes count under 200 cÚl/mm3 (64,7 percent) with a high-performance anti-retroviral therapy (54,7 percent). Risk factors of BP due to enterobacteria included age ³ 50 years (OR 2,50; 95 percent CI 1,40-15,1) and malnutrition (OR 2,53; 95 percent CI 1,83-7,91). Conclusions: It was demonstrated that the etiological agents identified in sputum from HIV/AIDS Cuban patients presenting with BP are similar to those described by other authors at international level, being more probable that the ill persons aged over 50 and also malnourished have a BP due to enterobacteria than remainder microorganisms

Neumotórax en pacientes con SIDA: Actualización sobre el tema / Pneumothorax in patients with AIDS: Update on the theme

La aparición de neumotórax como complicación de la neumonía por Pneumocistis carinii (PCP) en pacientes con SIDA, es muy frecuente desde los inicios de la pandemia en 1982, y comporta gran mortalidad. En este trabajo se reporta una serie de 25 pacientes con neumotórax como complicación de la Pneumocistis carinii en pacientes con SIDA, tratado por los autores durante cinco a ños de trabajo discontinuos en el cono sur africano: tres en Sudáfrica y dos en Zimbabwe. Se reportan los datos demográficos y el estado de los mismos al llegar a la sala de cirugía y su evolución después de tratados quirúrgicamente. La toracotomía fue necesaria en ocho pacientes (32 por ciento), diez pacientes necesitaron cuidados de terapia intensiva (40 por ciento), y la mortalidad global fue del 32 por ciento. Se revisa la información actualizada sobre el tema, destacando las pautas terapéuticas más aceptadas internacionalmente. Conflictos de interés: Los autores no declaran conflicto de interés con editores, patrocinadores ni otros autores.

Pneumothorax as a Pneumocistis carinii pneumonia complication in patients with AIDS is very frequent since the pandemic beginnings in 1982, and it is accompanied by a high mortality. In this work we report a series of 25 patients with Pneumothorax as a Pneumocistis carinii pneumonia complication in patients with AIDS, treated by the authors during five years of discontinuous work in the Southern Africa cone: three years in South Africa and two years in Zimbabwe. We report demographic data, the status of the patients when they arrived to the Surgery Service and their evolution after surgery. Thoracotomy was needed in eight patients (32 percent), ten patients needed intensive care (40 percent), and the global mortality was 32 percent. We review the updated information on the theme, emphasizing the most accepted therapeutic guidelines at the international level.

Histoplasmose: [revisão] / Histoplasmosis: [review]

A histoplasmose é uma micose causada por fungo dimórfico, o Histoplasma capsulatum. É considerada classicamente uma micose endêmica, embora o fungo tenha um comportamento oportunístico em pacientes com depressão da imunidade celular. O homem adquire a infecção através da inalação de conídeos presentes na natureza (cavernas com morcegos, galinheiros, etc). O quadro clínico pode variar, desde infecções assintomáticas até quadros graves disseminados, que acometem pacientes com Aids, transplantados ou com neoplasias hematológicas. O diagnóstico baseia-se no encontro do fungo em fluidos orgânicos (escarro, sangue, líquor) ou tecidos (histopatologia), na cultura de materiais biológicos e na sorologia. O tratamento das formas agudas graves, respiratória crônica ou de formas localizadas pode ser feito com azólicos orais (itraconazol) e nas disseminadas, a Anfotericina B (preferencialmente as formulações lipídicas) constitui a droga da eleição para iniciar a terapia. A histoplasmose representa, hoje uma das micoses sistêmicas mais importantes nas Américas, com ampla distribuição em todas as regiões do Brasil.

Histoplasmosis is a fungal infection caused by the dimorphic fungus Histoplasma capsulatum. It is classically considered an endemic mycosis, even though the fungus has an opportunistic behavior in immunocompromised patients. People acquired the infection through the inhalation of conidial forms present in the environmental, such as caves dwelling bats and soils inhabited by chickens. The clinical features may vary from asymptomatic infections to disseminated severe forms that affect patients with acquired immunodeficiency syndrome or hematological malignancies and allograft recipients. The diagnosis is based on the detection of the fungus in organic fluids (sputum, blood, liquor) or tissues (histopathological assays), in the culture of biological samples and serological assays. The treatment of severe chronic respiratory acute or localized forms can be performed with oral azolic (itraconazol) and in the disseminated forms, the amphotericin B (preferentially the lipidic formulations) consists in the elected drug to initiate the therapy. Nowadays, histoplasmosis represents one of the most important systemic mycosis in the Americas, with broad distribution in all regions of Brazil.

Frecuencia y distribución de las infecciones oportunistas en pacientes adultos con vih/sida en el hospital de Infectología de Guayaquil, enero a junio de 2005 / Frequency and distribution of opportunist infections in adult hiv/aids patients in Guayaquil Infectiology hospital, january to june/2005

No existe duda que en la actualidad el Síndrome de Inmunodeficiencia Adquirida (SIDA) es una de las más grandes amenazas en el ámbito de la salud mundial, con tres millones de muertes por año; en el mundo es la cuarta causa de mortalidad general y la primera por enfermedades infecciosas. Objetivo: conocer la frecuencia de las infecciones oportunistas; distribución por edad y sexo; la sintomatología en el momento de ingreso, por patología. Materiales y métodos: estudio retrospectivo de tipo transversal, descriptivo; universo de 215 pacientes que ingresaron al hospital de Infectología de Guayaquil, área de emergencia, enero a junio de 2005; se analizaron las historias clínicas de una muestra de 122 pacientes. Las variables fueron: edad, sexo, tiempo de evolución de VIH, tipo de infección oportunista, síntomas. Resultados: el sexo más afectado fue el masculino (76 y 24 respectivamente); la mayor parte de los pacientes eran menores de treinta años (42). La sintomatología más frecuente al ingreso fue la fiebre (24) y la infección oportunista de mayor ocurrencia fue la tuberculosis (42). La sintomatología respiratoria predominó en los pacientes con tuberculosis e histoplasmosis; las manifestaciones digestivas en la criptosporidiosis y colitis amebiana, y las neurológicas fueron característica de la toxoplasmosis y criptococosis. Conclusiones: se demuestra que en nuestro medio la tuberculosis es la infección oportunista más frecuente en los pacientes adultos con VIH/SIDA y que la manifestación clínica más común para ésta es la fiebre.

No doubt in present days, Acquired Immune Deficiency Syndrome (AIDS) is one of the biggest threatens in the world health realm, with three million deaths per year; it is the fourth cause of general mortality in the world, and the first one due to infectious deseases. Objective: to know the frequency of opportunist infections; age and sex distribution; symptoms at admission, by pathology. Materials and methodes: retrospective study, transversal type, descriptive; universe of 215 patients admitted in Guayaquil Ifectiology hospital, emergency area, from January to June/2005; the clinical records of a sample of 122 patients were checked. The variables were: age, sex, HIV evolution time, opportunist infection type, symptoms. Results: males were more affected (76 - M vs. 24- F); most of patients were younger than 30 years old (42). Most frequent symptoms at admission were fever (24), and the most frequent opportunist infection was tuberculosis (42). Respiratory symptoms predominated in tuberculosis and histoplasmosis patients; digestive signs in criptosporidiosis and amebic colitis, and neurologic signs were toxoplasmosis and criptococosis characteristics. Conclusions: it is proved that, in our environment, tuberculosis is the most frequent opportunist infection in adult HIV/AIDS patients and its most common sign is fever.

Enfrentamiento imaginológico de las lesiones cerebrales en pacientes VIH / Imaging approach to brain lesions in HIV patients

Human immunodeficiency virus (HIV) is a neurotropic virus that crosses the blood-brain barrier at early stages of the disease. Thus, the central nervous system (CNS) constitutes the major target of HIV, and according to estimations approximately two-thirds of patients will develop CNS involvement during the course of their disease. CNS diseases spectrum is wide and can be categorized into primary effects of HIV, opportunistic infections, neoplasms and vascular disease. A prompt diagnosis and treatment of such disorders is critical. Imaging studies play a crucial role in the diagnostic process. Therefore, characteristics of neuro-images in patients with HIV and their neurological manifestations have been reviewed.

El virus de inmunodeficiencia humana (VIH) es un virus neurotrópico que cruza la barrera hemato-encefálica en etapas precoces de la enfermedad. Es así como el sistema nervioso central (SNC) es blanco mayor del virus VIH, estimándose que aproximadamente dos tercios de los pacientes desarrollarán compromiso del SNC durante el curso de su enfermedad. El espectro de enfermedades del SNC es amplio y puede ser categorizado en: compromiso directo del virus VIH, infecciones oportunistas, neoplasias y enfermedad vascular. Un pronto diagnóstico y tratamiento de tales desordenes es crítico. Los estudios de imágenes juegan un rol crucial en el diagnóstico. Hemos revisado las características de las neuroimágenes en los pacientes VIH y sus manifestaciones neurológicas.

Tuberculosis y SIDA en el niño / HIV associated tuberculosis in children

La reemergencia de la tuberculosis a nivel mundial se vincula a diferentes factores dentro de los cuales está la infección VIH, esto también se ve reflejado en la población pediátrica, planteando dificultades en el diagnóstico y tratamiento oportuno, lo que obliga a tratar a nuestros niños por un equipo multidisciplinario.

Soft tissue abscess and lymphadenitis due to Mycobacterium avium Complex as an expression of immune reconstitution inflammatory syndrome after a second scheme of highly active antiretroviral therapy

Immune reconstitution inflammatory syndrome (IRIS) is an atypical and unexpected reaction related to highly active antiretroviral therapy (HAART) in human immunodeficiency virus (HIV) infected patients. IRIS includes an atypical response to an opportunistic pathogen (generally Mycobacterium tuberculosis, Mycobacterium avium complex, cytomegalovirus and herpes varicella-zoster), in patients responding to HAART with a reduction of plasma viral load and evidence of immune restoration based on increase of CD4+ T-cell count. We reported a case of a patient with AIDS which, after a first failure of HAART, developed a subcutaneous abscess and supraclavicular lymphadenitis as an expression of IRIS due to Mycobacterium avium complex after starting a second scheme of HAART.

El síndrome inflamatorio de reconstitución inmune (SIRI) es una reacción atípica e inesperada relacionada con el tratamiento antirretroviral de gran actividad (TARGA) en pacientes infectados por el virus de la inmunodeficiencia humana (VIH). El SIRI representa una respuesta inflamatoria frente a un patógeno oportunista (generalmente Mycobacterium tuberculosis, Complejo Mycobacterium avium, citomegalovirus y herpes varicela-zóster) en pacientes que responden a la TARGA con una marcada reducción de la carga viral en plasma y evidencia de una recuperación inmunológica expresada por el incremento de los niveles de linfocitos T CD4+. Presentamos el caso de un paciente con síndrome de inmunodeficiencia adquirida que desarrolló un absceso subcutáneo en muslo derecho y una adenitis supraclavicular izquierda como manifestación de SIRI por Complejo Mycobacterium avium luego del inicio de un segundo esquema de TARGA.

Cryptococcal meningoencephalitis diagnosed by blood culture.

Increase in cryptococcal infection has been noticed after acquired immunodeficiency syndrome pandemic. Cryptococcus neoformans can be isolated from blood in the process of dissemination to brain. We report a case of cryptococcal fungaemia in a patient whose cerebrospinal fluid was negative for Cryptococcus neoformans. Retrospective analysis revealed human immunodeficiency virus seropositivity of the patient. He was treated with amphotericin B and fluconazole. Antiretroviral therapy was started, however, the patient succumbed to the infection.

Condições oftalmológicas de pacientes com síndrome da imunodeficiência adquirida com longo tempo de seguimento / Ophthalmologic conditions of aids patients with long-term follow-up

OBJETIVO: Avaliar as condições oftalmológicas atuais de pacientes com síndrome da imunodeficiência adquirida (SIDA), previamente avaliados por oftalmologista, levando em consideração algumas características gerais relacionada com essa doença. MÉTODOS: Estudo observacional de 42 pacientes com SIDA, subdivididos em dois grupos: Grupo I: 8 pacientes com SIDA e diagnóstico prévio de retinite por citomegalovírus; Grupo II: 34 pacientes com SIDA sem retinite por citomegalovírus. Os dados gerais relacionados com a SIDA foram obtidos pela análise dos prontuários médicos. RESULTADOS: A maioria dos pacientes apresentou acuidade visual no melhor olho entre logMAR 0,0 (68,3 por cento) e 0,1 (26,9 por cento). Prescrição óptica para longe beneficiou 39,4 por cento dos pacientes do Grupo II mas nenhum dos paciente do Grupo I. Presbiopia foi corrigida em 27,3 por cento no Grupo II e 12,5 por cento no Grupo I. Não foram encontradas manifestações oculares atuais relacionadas a SIDA em nenhum dos grupos. As alterações fundoscópicas encontradas em 10 pacientes foram todas alterações cicatriciais de retinite/retinocoroidite, sendo 7 (16,7 por cento) pacientes pertencentes ao Grupo I e 3 (7,1 por cento) pacientes pertencentes ao Grupo II. CONCLUSÃO: Dez (24,4 por cento) pacientes apresentaram alteração visual decorrente do envelhecimento. Com exceção dos pacientes com cicatrizes prévias de retinite ou retinocoroidite, todos os outros participantes estavam em boas condições oftalmológicas e a maioria dos mesmos se encontrava em recuperação imunológica, devido ao uso da terapia anti-retroviral de alta potência.

PURPOSE: To evaluate the ophthalmologic conditions of patients with AIDS, with long-term follow-up, previously evaluated by an ophthalmologist, considering general conditions related with AIDS. METHODS: Observational study of 42 patients with AIDS divided into two groups: Group I: 8 patients with previous AIDS-related cytomegalovirus retinitis, Group II: 34 patients with AIDS without cytomegalovirus retinitis. Each patient had been submitted to one ophthalmologic examination. General data of the patients were obtained from the medical records. RESULTS: The majority of the patients presented visual acuity in the best eye between logMAR 0.0 (68.3 percent) and 0.1 (26.9 percent). Optic prescription for refractive errors benefited 39.4 percent of the patients in Group II but none of the patients in Group I. Presbyopia was corrected in 27.3 percent of Group II and in 12.5 percent of Group I patients. No current ocular AIDS-related manifestations were detected in any group. Ocular posterior segment alterations, all of them consisting of retinitis / retinochoroiditis scars, were found in 10 patients, 7 (16.7 percent) belonging to Group I and 3 (7.1 percent) to Group II. CONCLUSION: Ten (24.4 percent) patients presented visual alteration due to age. Except for the patients presenting previous retinitis and retinochoroiditis, all the other patients were in good ophthalmic conditions and most of them were in immunologic recovery due to the use of highly active antiretroviral therapy.